nodes	percent_of_prediction	percent_of_DWPC	metapath
Amisulpride—HTR7—nerve—acquired immunodeficiency syndrome	0.012	0.0741	CbGeAlD
Amisulpride—DRD2—nerve—acquired immunodeficiency syndrome	0.0113	0.07	CbGeAlD
Amisulpride—HTR7—endothelium—acquired immunodeficiency syndrome	0.0102	0.0631	CbGeAlD
Amisulpride—HTR7—blood plasma—acquired immunodeficiency syndrome	0.00907	0.056	CbGeAlD
Amisulpride—HTR2A—nerve—acquired immunodeficiency syndrome	0.00748	0.0462	CbGeAlD
Amisulpride—HTR2A—endothelium—acquired immunodeficiency syndrome	0.00637	0.0393	CbGeAlD
Amisulpride—DRD3—nervous system—acquired immunodeficiency syndrome	0.00603	0.0372	CbGeAlD
Amisulpride—DRD3—central nervous system—acquired immunodeficiency syndrome	0.0058	0.0359	CbGeAlD
Amisulpride—HTR2A—blood plasma—acquired immunodeficiency syndrome	0.00566	0.0349	CbGeAlD
Amisulpride—HTR2B—skin of body—acquired immunodeficiency syndrome	0.00509	0.0315	CbGeAlD
Amisulpride—DRD2—retina—acquired immunodeficiency syndrome	0.0047	0.029	CbGeAlD
Amisulpride—DRD3—brain—acquired immunodeficiency syndrome	0.00461	0.0285	CbGeAlD
Amisulpride—HTR2B—digestive system—acquired immunodeficiency syndrome	0.00407	0.0252	CbGeAlD
Amisulpride—HTR2B—blood—acquired immunodeficiency syndrome	0.00388	0.024	CbGeAlD
Amisulpride—HTR2B—vagina—acquired immunodeficiency syndrome	0.0036	0.0222	CbGeAlD
Amisulpride—HTR7—digestive system—acquired immunodeficiency syndrome	0.00349	0.0215	CbGeAlD
Amisulpride—HTR2B—lung—acquired immunodeficiency syndrome	0.0034	0.021	CbGeAlD
Amisulpride—HTR7—blood—acquired immunodeficiency syndrome	0.00332	0.0205	CbGeAlD
Amisulpride—HTR7—spinal cord—acquired immunodeficiency syndrome	0.0032	0.0198	CbGeAlD
Amisulpride—HTR2B—nervous system—acquired immunodeficiency syndrome	0.00315	0.0195	CbGeAlD
Amisulpride—HTR2A—retina—acquired immunodeficiency syndrome	0.0031	0.0191	CbGeAlD
Amisulpride—HTR2B—central nervous system—acquired immunodeficiency syndrome	0.00303	0.0187	CbGeAlD
Amisulpride—HTR7—lung—acquired immunodeficiency syndrome	0.00291	0.018	CbGeAlD
Amisulpride—DRD2—lung—acquired immunodeficiency syndrome	0.00275	0.017	CbGeAlD
Amisulpride—HTR7—nervous system—acquired immunodeficiency syndrome	0.0027	0.0167	CbGeAlD
Amisulpride—HTR7—central nervous system—acquired immunodeficiency syndrome	0.0026	0.016	CbGeAlD
Amisulpride—DRD2—nervous system—acquired immunodeficiency syndrome	0.00255	0.0158	CbGeAlD
Amisulpride—DRD2—central nervous system—acquired immunodeficiency syndrome	0.00246	0.0152	CbGeAlD
Amisulpride—HTR2B—brain—acquired immunodeficiency syndrome	0.00241	0.0149	CbGeAlD
Amisulpride—HTR2B—lymph node—acquired immunodeficiency syndrome	0.00233	0.0144	CbGeAlD
Amisulpride—HTR2A—digestive system—acquired immunodeficiency syndrome	0.00218	0.0134	CbGeAlD
Amisulpride—HTR2A—blood—acquired immunodeficiency syndrome	0.00207	0.0128	CbGeAlD
Amisulpride—HTR7—brain—acquired immunodeficiency syndrome	0.00206	0.0127	CbGeAlD
Amisulpride—HTR2A—spinal cord—acquired immunodeficiency syndrome	0.002	0.0123	CbGeAlD
Amisulpride—DRD2—brain—acquired immunodeficiency syndrome	0.00195	0.012	CbGeAlD
Amisulpride—HTR2A—vagina—acquired immunodeficiency syndrome	0.00192	0.0119	CbGeAlD
Amisulpride—HTR2A—lung—acquired immunodeficiency syndrome	0.00182	0.0112	CbGeAlD
Amisulpride—HTR2A—nervous system—acquired immunodeficiency syndrome	0.00168	0.0104	CbGeAlD
Amisulpride—HTR2A—central nervous system—acquired immunodeficiency syndrome	0.00162	0.01	CbGeAlD
Amisulpride—Gastrointestinal disorder—Abacavir—acquired immunodeficiency syndrome	0.00152	0.00204	CcSEcCtD
Amisulpride—Cardiac disorder—Saquinavir—acquired immunodeficiency syndrome	0.00152	0.00204	CcSEcCtD
Amisulpride—Fatigue—Abacavir—acquired immunodeficiency syndrome	0.00152	0.00204	CcSEcCtD
Amisulpride—Hypersensitivity—Didanosine—acquired immunodeficiency syndrome	0.00152	0.00203	CcSEcCtD
Amisulpride—Gastrointestinal pain—Nevirapine—acquired immunodeficiency syndrome	0.00152	0.00203	CcSEcCtD
Amisulpride—Skin disorder—Zidovudine—acquired immunodeficiency syndrome	0.00151	0.00202	CcSEcCtD
Amisulpride—Anxiety—Indinavir—acquired immunodeficiency syndrome	0.0015	0.00201	CcSEcCtD
Amisulpride—Hyperhidrosis—Zidovudine—acquired immunodeficiency syndrome	0.0015	0.00201	CcSEcCtD
Amisulpride—Tremor—Delavirdine—acquired immunodeficiency syndrome	0.0015	0.00201	CcSEcCtD
Amisulpride—Unspecified disorder of skin and subcutaneous tissue—Indinavir—acquired immunodeficiency syndrome	0.0015	0.00201	CcSEcCtD
Amisulpride—Mental disorder—Ritonavir—acquired immunodeficiency syndrome	0.00149	0.002	CcSEcCtD
Amisulpride—Angiopathy—Saquinavir—acquired immunodeficiency syndrome	0.00149	0.00199	CcSEcCtD
Amisulpride—Malnutrition—Ritonavir—acquired immunodeficiency syndrome	0.00148	0.00199	CcSEcCtD
Amisulpride—Immune system disorder—Saquinavir—acquired immunodeficiency syndrome	0.00148	0.00198	CcSEcCtD
Amisulpride—Asthenia—Didanosine—acquired immunodeficiency syndrome	0.00148	0.00198	CcSEcCtD
Amisulpride—Dry mouth—Indinavir—acquired immunodeficiency syndrome	0.00148	0.00198	CcSEcCtD
Amisulpride—Agitation—Delavirdine—acquired immunodeficiency syndrome	0.00147	0.00197	CcSEcCtD
Amisulpride—Urticaria—Nevirapine—acquired immunodeficiency syndrome	0.00147	0.00197	CcSEcCtD
Amisulpride—Gastrointestinal pain—Nelfinavir—acquired immunodeficiency syndrome	0.00147	0.00197	CcSEcCtD
Amisulpride—Abdominal pain—Nevirapine—acquired immunodeficiency syndrome	0.00147	0.00196	CcSEcCtD
Amisulpride—Angioedema—Delavirdine—acquired immunodeficiency syndrome	0.00146	0.00196	CcSEcCtD
Amisulpride—Gastrointestinal pain—Stavudine—acquired immunodeficiency syndrome	0.00146	0.00196	CcSEcCtD
Amisulpride—Pruritus—Didanosine—acquired immunodeficiency syndrome	0.00146	0.00195	CcSEcCtD
Amisulpride—Tension—Ritonavir—acquired immunodeficiency syndrome	0.00145	0.00195	CcSEcCtD
Amisulpride—Convulsion—Efavirenz—acquired immunodeficiency syndrome	0.00145	0.00194	CcSEcCtD
Amisulpride—Hypertension—Efavirenz—acquired immunodeficiency syndrome	0.00145	0.00194	CcSEcCtD
Amisulpride—Gastrointestinal pain—Abacavir—acquired immunodeficiency syndrome	0.00144	0.00193	CcSEcCtD
Amisulpride—Nervousness—Ritonavir—acquired immunodeficiency syndrome	0.00144	0.00193	CcSEcCtD
Amisulpride—Vomiting—Amprenavir—acquired immunodeficiency syndrome	0.00144	0.00193	CcSEcCtD
Amisulpride—Mental disorder—Saquinavir—acquired immunodeficiency syndrome	0.00144	0.00192	CcSEcCtD
Amisulpride—Leukopenia—Delavirdine—acquired immunodeficiency syndrome	0.00143	0.00192	CcSEcCtD
Amisulpride—Malnutrition—Saquinavir—acquired immunodeficiency syndrome	0.00143	0.00191	CcSEcCtD
Amisulpride—Urticaria—Nelfinavir—acquired immunodeficiency syndrome	0.00143	0.00191	CcSEcCtD
Amisulpride—Muscle spasms—Ritonavir—acquired immunodeficiency syndrome	0.00142	0.00191	CcSEcCtD
Amisulpride—Urticaria—Stavudine—acquired immunodeficiency syndrome	0.00142	0.0019	CcSEcCtD
Amisulpride—Anxiety—Efavirenz—acquired immunodeficiency syndrome	0.00142	0.0019	CcSEcCtD
Amisulpride—Abdominal pain—Nelfinavir—acquired immunodeficiency syndrome	0.00142	0.0019	CcSEcCtD
Amisulpride—Nervous system disorder—Indinavir—acquired immunodeficiency syndrome	0.00142	0.0019	CcSEcCtD
Amisulpride—Headache—Amprenavir—acquired immunodeficiency syndrome	0.00142	0.0019	CcSEcCtD
Amisulpride—Unspecified disorder of skin and subcutaneous tissue—Efavirenz—acquired immunodeficiency syndrome	0.00142	0.0019	CcSEcCtD
Amisulpride—Abdominal pain—Stavudine—acquired immunodeficiency syndrome	0.00141	0.0019	CcSEcCtD
Amisulpride—Immune system disorder—Lamivudine—acquired immunodeficiency syndrome	0.00141	0.00189	CcSEcCtD
Amisulpride—Diarrhoea—Didanosine—acquired immunodeficiency syndrome	0.00141	0.00189	CcSEcCtD
Amisulpride—Insomnia—Zidovudine—acquired immunodeficiency syndrome	0.00141	0.00188	CcSEcCtD
Amisulpride—Skin disorder—Indinavir—acquired immunodeficiency syndrome	0.00141	0.00188	CcSEcCtD
Amisulpride—Urticaria—Abacavir—acquired immunodeficiency syndrome	0.0014	0.00188	CcSEcCtD
Amisulpride—Hyperhidrosis—Indinavir—acquired immunodeficiency syndrome	0.0014	0.00187	CcSEcCtD
Amisulpride—Dry mouth—Efavirenz—acquired immunodeficiency syndrome	0.00139	0.00187	CcSEcCtD
Amisulpride—Abdominal pain—Abacavir—acquired immunodeficiency syndrome	0.00139	0.00187	CcSEcCtD
Amisulpride—Tremor—Ritonavir—acquired immunodeficiency syndrome	0.00139	0.00186	CcSEcCtD
Amisulpride—Hypertension—Delavirdine—acquired immunodeficiency syndrome	0.00138	0.00185	CcSEcCtD
Amisulpride—Somnolence—Zidovudine—acquired immunodeficiency syndrome	0.00138	0.00185	CcSEcCtD
Amisulpride—Muscle spasms—Saquinavir—acquired immunodeficiency syndrome	0.00137	0.00184	CcSEcCtD
Amisulpride—Dyspepsia—Zidovudine—acquired immunodeficiency syndrome	0.00137	0.00183	CcSEcCtD
Amisulpride—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	0.00137	0.00183	CcSEcCtD
Amisulpride—Agitation—Ritonavir—acquired immunodeficiency syndrome	0.00136	0.00182	CcSEcCtD
Amisulpride—Malnutrition—Lamivudine—acquired immunodeficiency syndrome	0.00136	0.00182	CcSEcCtD
Amisulpride—Anxiety—Delavirdine—acquired immunodeficiency syndrome	0.00136	0.00182	CcSEcCtD
Amisulpride—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.00134	0.0018	CcSEcCtD
Amisulpride—Gastrointestinal disorder—Zidovudine—acquired immunodeficiency syndrome	0.00134	0.0018	CcSEcCtD
Amisulpride—Fatigue—Zidovudine—acquired immunodeficiency syndrome	0.00134	0.0018	CcSEcCtD
Amisulpride—Nervous system disorder—Efavirenz—acquired immunodeficiency syndrome	0.00134	0.0018	CcSEcCtD
Amisulpride—Tremor—Saquinavir—acquired immunodeficiency syndrome	0.00134	0.00179	CcSEcCtD
Amisulpride—Tension—Lamivudine—acquired immunodeficiency syndrome	0.00134	0.00179	CcSEcCtD
Amisulpride—Dry mouth—Delavirdine—acquired immunodeficiency syndrome	0.00133	0.00179	CcSEcCtD
Amisulpride—Constipation—Zidovudine—acquired immunodeficiency syndrome	0.00133	0.00178	CcSEcCtD
Amisulpride—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.00133	0.00178	CcSEcCtD
Amisulpride—Skin disorder—Efavirenz—acquired immunodeficiency syndrome	0.00133	0.00178	CcSEcCtD
Amisulpride—Leukopenia—Ritonavir—acquired immunodeficiency syndrome	0.00133	0.00178	CcSEcCtD
Amisulpride—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.00132	0.00177	CcSEcCtD
Amisulpride—Nervousness—Lamivudine—acquired immunodeficiency syndrome	0.00132	0.00177	CcSEcCtD
Amisulpride—Hyperhidrosis—Efavirenz—acquired immunodeficiency syndrome	0.00132	0.00177	CcSEcCtD
Amisulpride—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.00132	0.00177	CcSEcCtD
Amisulpride—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.00131	0.00176	CcSEcCtD
Amisulpride—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.00131	0.00176	CcSEcCtD
Amisulpride—Agitation—Saquinavir—acquired immunodeficiency syndrome	0.00131	0.00176	CcSEcCtD
Amisulpride—Insomnia—Indinavir—acquired immunodeficiency syndrome	0.00131	0.00175	CcSEcCtD
Amisulpride—Muscle spasms—Lamivudine—acquired immunodeficiency syndrome	0.00131	0.00175	CcSEcCtD
Amisulpride—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.0013	0.00174	CcSEcCtD
Amisulpride—Headache—Didanosine—acquired immunodeficiency syndrome	0.00129	0.00173	CcSEcCtD
Amisulpride—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.00129	0.00173	CcSEcCtD
Amisulpride—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.00129	0.00172	CcSEcCtD
Amisulpride—HTR2A—brain—acquired immunodeficiency syndrome	0.00129	0.00794	CbGeAlD
Amisulpride—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.00128	0.00172	CcSEcCtD
Amisulpride—Convulsion—Ritonavir—acquired immunodeficiency syndrome	0.00128	0.00172	CcSEcCtD
Amisulpride—Hypertension—Ritonavir—acquired immunodeficiency syndrome	0.00128	0.00171	CcSEcCtD
Amisulpride—Leukopenia—Saquinavir—acquired immunodeficiency syndrome	0.00128	0.00171	CcSEcCtD
Amisulpride—Tremor—Lamivudine—acquired immunodeficiency syndrome	0.00127	0.00171	CcSEcCtD
Amisulpride—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.00127	0.00171	CcSEcCtD
Amisulpride—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.00127	0.0017	CcSEcCtD
Amisulpride—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	0.00127	0.0017	CcSEcCtD
Amisulpride—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.00127	0.0017	CcSEcCtD
Amisulpride—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.00127	0.0017	CcSEcCtD
Amisulpride—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.00127	0.0017	CcSEcCtD
Amisulpride—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.00126	0.00169	CcSEcCtD
Amisulpride—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.00126	0.00169	CcSEcCtD
Amisulpride—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.00126	0.00168	CcSEcCtD
Amisulpride—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.00125	0.00168	CcSEcCtD
Amisulpride—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.00125	0.00167	CcSEcCtD
Amisulpride—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.00125	0.00167	CcSEcCtD
Amisulpride—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.00125	0.00167	CcSEcCtD
Amisulpride—Angioedema—Lamivudine—acquired immunodeficiency syndrome	0.00124	0.00167	CcSEcCtD
Amisulpride—Constipation—Indinavir—acquired immunodeficiency syndrome	0.00124	0.00166	CcSEcCtD
Amisulpride—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.00124	0.00166	CcSEcCtD
Amisulpride—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.00124	0.00166	CcSEcCtD
Amisulpride—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.00124	0.00166	CcSEcCtD
Amisulpride—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.00123	0.00165	CcSEcCtD
Amisulpride—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.00123	0.00165	CcSEcCtD
Amisulpride—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.00123	0.00165	CcSEcCtD
Amisulpride—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.00123	0.00165	CcSEcCtD
Amisulpride—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.00122	0.00164	CcSEcCtD
Amisulpride—Nausea—Didanosine—acquired immunodeficiency syndrome	0.00122	0.00164	CcSEcCtD
Amisulpride—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.00122	0.00164	CcSEcCtD
Amisulpride—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	0.00122	0.00163	CcSEcCtD
Amisulpride—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.00122	0.00163	CcSEcCtD
Amisulpride—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.00121	0.00162	CcSEcCtD
Amisulpride—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.00121	0.00162	CcSEcCtD
Amisulpride—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.00121	0.00162	CcSEcCtD
Amisulpride—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.0012	0.00161	CcSEcCtD
Amisulpride—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.00119	0.00159	CcSEcCtD
Amisulpride—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.00119	0.00159	CcSEcCtD
Amisulpride—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.00119	0.00159	CcSEcCtD
Amisulpride—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.00118	0.00159	CcSEcCtD
Amisulpride—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.00118	0.00158	CcSEcCtD
Amisulpride—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.00118	0.00158	CcSEcCtD
Amisulpride—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.00118	0.00158	CcSEcCtD
Amisulpride—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.00118	0.00158	CcSEcCtD
Amisulpride—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.00118	0.00158	CcSEcCtD
Amisulpride—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.00118	0.00158	CcSEcCtD
Amisulpride—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.00117	0.00157	CcSEcCtD
Amisulpride—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.00117	0.00157	CcSEcCtD
Amisulpride—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.00117	0.00157	CcSEcCtD
Amisulpride—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.00117	0.00156	CcSEcCtD
Amisulpride—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.00116	0.00156	CcSEcCtD
Amisulpride—Headache—Nevirapine—acquired immunodeficiency syndrome	0.00116	0.00156	CcSEcCtD
Amisulpride—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.00115	0.00155	CcSEcCtD
Amisulpride—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.00115	0.00154	CcSEcCtD
Amisulpride—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.00115	0.00154	CcSEcCtD
Amisulpride—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.00115	0.00154	CcSEcCtD
Amisulpride—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.00114	0.00153	CcSEcCtD
Amisulpride—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.00114	0.00153	CcSEcCtD
Amisulpride—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.00114	0.00153	CcSEcCtD
Amisulpride—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.00114	0.00152	CcSEcCtD
Amisulpride—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.00113	0.00152	CcSEcCtD
Amisulpride—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.00113	0.00151	CcSEcCtD
Amisulpride—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.00113	0.00151	CcSEcCtD
Amisulpride—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.00113	0.00151	CcSEcCtD
Amisulpride—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.00113	0.00151	CcSEcCtD
Amisulpride—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.00113	0.00151	CcSEcCtD
Amisulpride—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.00112	0.00151	CcSEcCtD
Amisulpride—Headache—Stavudine—acquired immunodeficiency syndrome	0.00112	0.0015	CcSEcCtD
Amisulpride—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.00112	0.0015	CcSEcCtD
Amisulpride—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.00112	0.0015	CcSEcCtD
Amisulpride—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.00112	0.0015	CcSEcCtD
Amisulpride—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.00112	0.0015	CcSEcCtD
Amisulpride—Headache—Abacavir—acquired immunodeficiency syndrome	0.0011	0.00148	CcSEcCtD
Amisulpride—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.0011	0.00148	CcSEcCtD
Amisulpride—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.0011	0.00147	CcSEcCtD
Amisulpride—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.00109	0.00147	CcSEcCtD
Amisulpride—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.00109	0.00146	CcSEcCtD
Amisulpride—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.00109	0.00146	CcSEcCtD
Amisulpride—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.00109	0.00145	CcSEcCtD
Amisulpride—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.00108	0.00145	CcSEcCtD
Amisulpride—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.00108	0.00145	CcSEcCtD
Amisulpride—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.00108	0.00144	CcSEcCtD
Amisulpride—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.00107	0.00144	CcSEcCtD
Amisulpride—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.00107	0.00143	CcSEcCtD
Amisulpride—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.00107	0.00143	CcSEcCtD
Amisulpride—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.00107	0.00143	CcSEcCtD
Amisulpride—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.00106	0.00143	CcSEcCtD
Amisulpride—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.00106	0.00143	CcSEcCtD
Amisulpride—Nausea—Stavudine—acquired immunodeficiency syndrome	0.00106	0.00142	CcSEcCtD
Amisulpride—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.00105	0.00141	CcSEcCtD
Amisulpride—Nausea—Abacavir—acquired immunodeficiency syndrome	0.00105	0.0014	CcSEcCtD
Amisulpride—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.00104	0.0014	CcSEcCtD
Amisulpride—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.00104	0.0014	CcSEcCtD
Amisulpride—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.00104	0.00139	CcSEcCtD
Amisulpride—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.00104	0.00139	CcSEcCtD
Amisulpride—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.00104	0.00139	CcSEcCtD
Amisulpride—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.00103	0.00139	CcSEcCtD
Amisulpride—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.00103	0.00139	CcSEcCtD
Amisulpride—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.00103	0.00139	CcSEcCtD
Amisulpride—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.00103	0.00138	CcSEcCtD
Amisulpride—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.00102	0.00137	CcSEcCtD
Amisulpride—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.00102	0.00137	CcSEcCtD
Amisulpride—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.00101	0.00135	CcSEcCtD
Amisulpride—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.001	0.00135	CcSEcCtD
Amisulpride—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.001	0.00135	CcSEcCtD
Amisulpride—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.001	0.00134	CcSEcCtD
Amisulpride—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.000995	0.00133	CcSEcCtD
Amisulpride—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.00099	0.00133	CcSEcCtD
Amisulpride—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000989	0.00133	CcSEcCtD
Amisulpride—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000989	0.00132	CcSEcCtD
Amisulpride—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.000987	0.00132	CcSEcCtD
Amisulpride—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000981	0.00131	CcSEcCtD
Amisulpride—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.000977	0.00131	CcSEcCtD
Amisulpride—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000974	0.00131	CcSEcCtD
Amisulpride—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000967	0.0013	CcSEcCtD
Amisulpride—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000964	0.00129	CcSEcCtD
Amisulpride—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.000961	0.00129	CcSEcCtD
Amisulpride—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000959	0.00128	CcSEcCtD
Amisulpride—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.000957	0.00128	CcSEcCtD
Amisulpride—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000957	0.00128	CcSEcCtD
Amisulpride—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.000956	0.00128	CcSEcCtD
Amisulpride—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.000952	0.00128	CcSEcCtD
Amisulpride—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.00095	0.00127	CcSEcCtD
Amisulpride—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000938	0.00126	CcSEcCtD
Amisulpride—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000935	0.00125	CcSEcCtD
Amisulpride—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000925	0.00124	CcSEcCtD
Amisulpride—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000925	0.00124	CcSEcCtD
Amisulpride—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000924	0.00124	CcSEcCtD
Amisulpride—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.00092	0.00123	CcSEcCtD
Amisulpride—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.00092	0.00123	CcSEcCtD
Amisulpride—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.000908	0.00122	CcSEcCtD
Amisulpride—Headache—Indinavir—acquired immunodeficiency syndrome	0.000906	0.00121	CcSEcCtD
Amisulpride—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000904	0.00121	CcSEcCtD
Amisulpride—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000895	0.0012	CcSEcCtD
Amisulpride—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000891	0.00119	CcSEcCtD
Amisulpride—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000882	0.00118	CcSEcCtD
Amisulpride—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.000878	0.00118	CcSEcCtD
Amisulpride—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000869	0.00116	CcSEcCtD
Amisulpride—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000868	0.00116	CcSEcCtD
Amisulpride—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000865	0.00116	CcSEcCtD
Amisulpride—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000859	0.00115	CcSEcCtD
Amisulpride—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000858	0.00115	CcSEcCtD
Amisulpride—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000856	0.00115	CcSEcCtD
Amisulpride—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000856	0.00115	CcSEcCtD
Amisulpride—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000835	0.00112	CcSEcCtD
Amisulpride—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000832	0.00111	CcSEcCtD
Amisulpride—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000827	0.00111	CcSEcCtD
Amisulpride—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.000824	0.0011	CcSEcCtD
Amisulpride—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000819	0.0011	CcSEcCtD
Amisulpride—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.000818	0.0011	CcSEcCtD
Amisulpride—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000812	0.00109	CcSEcCtD
Amisulpride—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.0008	0.00107	CcSEcCtD
Amisulpride—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000797	0.00107	CcSEcCtD
Amisulpride—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000796	0.00107	CcSEcCtD
Amisulpride—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.000786	0.00105	CcSEcCtD
Amisulpride—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000777	0.00104	CcSEcCtD
Amisulpride—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.00077	0.00103	CcSEcCtD
Amisulpride—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000769	0.00103	CcSEcCtD
Amisulpride—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.00076	0.00102	CcSEcCtD
Amisulpride—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000758	0.00102	CcSEcCtD
Amisulpride—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.00074	0.000992	CcSEcCtD
Amisulpride—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000734	0.000984	CcSEcCtD
Amisulpride—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000729	0.000977	CcSEcCtD
Amisulpride—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000718	0.000962	CcSEcCtD
Amisulpride—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000706	0.000946	CcSEcCtD
Amisulpride—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000696	0.000932	CcSEcCtD
Amisulpride—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000691	0.000926	CcSEcCtD
Amisulpride—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.00066	0.000884	CcSEcCtD
Amisulpride—HTR2B—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.000514	0.0056	CbGpPWpGaD
Amisulpride—DRD3—G alpha (i) signalling events—CXCR4—acquired immunodeficiency syndrome	0.000511	0.00557	CbGpPWpGaD
Amisulpride—DRD3—G alpha (i) signalling events—CXCL12—acquired immunodeficiency syndrome	0.000511	0.00557	CbGpPWpGaD
Amisulpride—HTR2B—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	0.00051	0.00556	CbGpPWpGaD
Amisulpride—HTR7—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.000508	0.00554	CbGpPWpGaD
Amisulpride—DRD3—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	0.000504	0.0055	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.000499	0.00544	CbGpPWpGaD
Amisulpride—HTR7—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.000478	0.00521	CbGpPWpGaD
Amisulpride—DRD3—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.000478	0.00521	CbGpPWpGaD
Amisulpride—HTR7—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.000478	0.00521	CbGpPWpGaD
Amisulpride—DRD3—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	0.000474	0.00517	CbGpPWpGaD
Amisulpride—HTR2B—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.000464	0.00507	CbGpPWpGaD
Amisulpride—DRD2—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.000451	0.00492	CbGpPWpGaD
Amisulpride—HTR2A—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.000443	0.00484	CbGpPWpGaD
Amisulpride—HTR2B—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.000437	0.00476	CbGpPWpGaD
Amisulpride—HTR2B—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.000437	0.00476	CbGpPWpGaD
Amisulpride—DRD3—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.000432	0.00471	CbGpPWpGaD
Amisulpride—HTR7—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.000428	0.00467	CbGpPWpGaD
Amisulpride—DRD2—G alpha (i) signalling events—CCR2—acquired immunodeficiency syndrome	0.000416	0.00454	CbGpPWpGaD
Amisulpride—DRD2—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.000408	0.00445	CbGpPWpGaD
Amisulpride—DRD3—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.000406	0.00443	CbGpPWpGaD
Amisulpride—DRD3—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.000406	0.00443	CbGpPWpGaD
Amisulpride—HTR2A—SIDS Susceptibility Pathways—IL10—acquired immunodeficiency syndrome	0.000405	0.00442	CbGpPWpGaD
Amisulpride—HTR2A—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.000401	0.00438	CbGpPWpGaD
Amisulpride—HTR2B—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.000391	0.00427	CbGpPWpGaD
Amisulpride—DRD2—G alpha (i) signalling events—CXCL12—acquired immunodeficiency syndrome	0.000391	0.00427	CbGpPWpGaD
Amisulpride—DRD2—G alpha (i) signalling events—CXCR4—acquired immunodeficiency syndrome	0.000391	0.00427	CbGpPWpGaD
Amisulpride—DRD3—G alpha (i) signalling events—CCL5—acquired immunodeficiency syndrome	0.000389	0.00424	CbGpPWpGaD
Amisulpride—HTR7—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.000387	0.00422	CbGpPWpGaD
Amisulpride—DRD2—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	0.000386	0.00421	CbGpPWpGaD
Amisulpride—HTR7—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.000382	0.00417	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.000382	0.00416	CbGpPWpGaD
Amisulpride—HTR2A—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	0.00038	0.00414	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.000376	0.0041	CbGpPWpGaD
Amisulpride—DRD2—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.000366	0.00399	CbGpPWpGaD
Amisulpride—HTR7—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.000364	0.00397	CbGpPWpGaD
Amisulpride—HTR7—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.000364	0.00397	CbGpPWpGaD
Amisulpride—DRD3—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.000364	0.00397	CbGpPWpGaD
Amisulpride—HTR7—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.000364	0.00397	CbGpPWpGaD
Amisulpride—DRD2—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	0.000363	0.00396	CbGpPWpGaD
Amisulpride—HTR2A—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.00036	0.00393	CbGpPWpGaD
Amisulpride—HTR2A—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	0.000357	0.0039	CbGpPWpGaD
Amisulpride—HTR7—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.000355	0.00388	CbGpPWpGaD
Amisulpride—HTR2B—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.000354	0.00386	CbGpPWpGaD
Amisulpride—DRD3—G alpha (i) signalling events—CCR5—acquired immunodeficiency syndrome	0.00035	0.00382	CbGpPWpGaD
Amisulpride—HTR2B—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.000349	0.00381	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000347	0.00378	CbGpPWpGaD
Amisulpride—HTR2B—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.000333	0.00363	CbGpPWpGaD
Amisulpride—HTR2B—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.000333	0.00363	CbGpPWpGaD
Amisulpride—HTR2B—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.000332	0.00362	CbGpPWpGaD
Amisulpride—DRD2—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.000331	0.00361	CbGpPWpGaD
Amisulpride—DRD3—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.000329	0.00359	CbGpPWpGaD
Amisulpride—HTR7—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.000328	0.00357	CbGpPWpGaD
Amisulpride—HTR2A—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.000325	0.00355	CbGpPWpGaD
Amisulpride—DRD3—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.000325	0.00355	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.000325	0.00354	CbGpPWpGaD
Amisulpride—HTR7—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.000321	0.00351	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000317	0.00346	CbGpPWpGaD
Amisulpride—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.000311	0.00339	CbGpPWpGaD
Amisulpride—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.000311	0.00339	CbGpPWpGaD
Amisulpride—DRD3—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.000309	0.00338	CbGpPWpGaD
Amisulpride—DRD3—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.000309	0.00338	CbGpPWpGaD
Amisulpride—DRD3—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.000309	0.00337	CbGpPWpGaD
Amisulpride—HTR2A—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.000306	0.00334	CbGpPWpGaD
Amisulpride—HTR2A—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.000306	0.00334	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.000302	0.0033	CbGpPWpGaD
Amisulpride—HTR2B—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.000299	0.00327	CbGpPWpGaD
Amisulpride—DRD2—G alpha (i) signalling events—CCL5—acquired immunodeficiency syndrome	0.000297	0.00325	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000295	0.00322	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.000294	0.00321	CbGpPWpGaD
Amisulpride—DRD3—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.000278	0.00304	CbGpPWpGaD
Amisulpride—DRD2—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.000278	0.00304	CbGpPWpGaD
Amisulpride—HTR7—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.000277	0.00302	CbGpPWpGaD
Amisulpride—HTR2A—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.000274	0.00299	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.000273	0.00298	CbGpPWpGaD
Amisulpride—DRD2—G alpha (i) signalling events—CCR5—acquired immunodeficiency syndrome	0.000268	0.00292	CbGpPWpGaD
Amisulpride—HTR2B—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.000253	0.00276	CbGpPWpGaD
Amisulpride—DRD2—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.000252	0.00275	CbGpPWpGaD
Amisulpride—HTR7—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.000249	0.00272	CbGpPWpGaD
Amisulpride—DRD2—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.000249	0.00271	CbGpPWpGaD
Amisulpride—HTR2A—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.000248	0.0027	CbGpPWpGaD
Amisulpride—HTR2A—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.000245	0.00267	CbGpPWpGaD
Amisulpride—DRD2—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.000237	0.00258	CbGpPWpGaD
Amisulpride—DRD2—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.000237	0.00258	CbGpPWpGaD
Amisulpride—DRD2—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.000237	0.00258	CbGpPWpGaD
Amisulpride—DRD3—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.000235	0.00257	CbGpPWpGaD
Amisulpride—HTR2A—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.000233	0.00254	CbGpPWpGaD
Amisulpride—HTR2A—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.000233	0.00254	CbGpPWpGaD
Amisulpride—HTR2A—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.000233	0.00254	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.000231	0.00252	CbGpPWpGaD
Amisulpride—HTR2B—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.000228	0.00249	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.000228	0.00248	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000226	0.00246	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000222	0.00242	CbGpPWpGaD
Amisulpride—HTR7—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.00022	0.0024	CbGpPWpGaD
Amisulpride—HTR7—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000219	0.00239	CbGpPWpGaD
Amisulpride—DRD2—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.000213	0.00232	CbGpPWpGaD
Amisulpride—DRD3—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.000212	0.00231	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.00021	0.00229	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.00021	0.00229	CbGpPWpGaD
Amisulpride—HTR2A—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.00021	0.00229	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.000209	0.00228	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.000206	0.00225	CbGpPWpGaD
Amisulpride—HTR7—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000206	0.00224	CbGpPWpGaD
Amisulpride—HTR7—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000206	0.00224	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000201	0.00219	CbGpPWpGaD
Amisulpride—HTR2B—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.0002	0.00218	CbGpPWpGaD
Amisulpride—HTR7—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000199	0.00217	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000192	0.00209	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000192	0.00209	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.00019	0.00207	CbGpPWpGaD
Amisulpride—HTR2B—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000188	0.00205	CbGpPWpGaD
Amisulpride—HTR2B—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000188	0.00205	CbGpPWpGaD
Amisulpride—HTR7—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000187	0.00204	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000187	0.00204	CbGpPWpGaD
Amisulpride—HTR7—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000187	0.00204	CbGpPWpGaD
Amisulpride—DRD3—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000186	0.00203	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000181	0.00198	CbGpPWpGaD
Amisulpride—DRD2—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.00018	0.00196	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000179	0.00195	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000179	0.00195	CbGpPWpGaD
Amisulpride—HTR2A—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.000177	0.00193	CbGpPWpGaD
Amisulpride—DRD3—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000175	0.00191	CbGpPWpGaD
Amisulpride—DRD3—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000175	0.00191	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000174	0.00189	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000171	0.00186	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000171	0.00186	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000169	0.00184	CbGpPWpGaD
Amisulpride—DRD2—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.000162	0.00177	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000161	0.00176	CbGpPWpGaD
Amisulpride—HTR2A—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.00016	0.00174	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000159	0.00173	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000159	0.00173	CbGpPWpGaD
Amisulpride—HTR7—Circadian rythm related genes—IL6—acquired immunodeficiency syndrome	0.000159	0.00173	CbGpPWpGaD
Amisulpride—HTR7—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000156	0.00171	CbGpPWpGaD
Amisulpride—HTR7—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000154	0.00168	CbGpPWpGaD
Amisulpride—HTR2A—SIDS Susceptibility Pathways—TNF—acquired immunodeficiency syndrome	0.000154	0.00168	CbGpPWpGaD
Amisulpride—HTR2B—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000143	0.00156	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000143	0.00156	CbGpPWpGaD
Amisulpride—DRD2—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000142	0.00155	CbGpPWpGaD
Amisulpride—HTR7—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000142	0.00155	CbGpPWpGaD
Amisulpride—HTR7—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000141	0.00154	CbGpPWpGaD
Amisulpride—HTR2B—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000141	0.00154	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000141	0.00153	CbGpPWpGaD
Amisulpride—HTR2A—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.00014	0.00153	CbGpPWpGaD
Amisulpride—HTR7—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.00014	0.00153	CbGpPWpGaD
Amisulpride—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	0.000137	0.0015	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000137	0.00149	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000137	0.00149	CbGpPWpGaD
Amisulpride—DRD3—Circadian rythm related genes—IL6—acquired immunodeficiency syndrome	0.000135	0.00147	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000134	0.00147	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000134	0.00147	CbGpPWpGaD
Amisulpride—DRD2—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000134	0.00146	CbGpPWpGaD
Amisulpride—DRD2—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000134	0.00146	CbGpPWpGaD
Amisulpride—DRD3—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000133	0.00145	CbGpPWpGaD
Amisulpride—HTR2A—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000132	0.00144	CbGpPWpGaD
Amisulpride—HTR2A—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000132	0.00144	CbGpPWpGaD
Amisulpride—DRD3—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000131	0.00143	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.00013	0.00142	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.00013	0.00142	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000129	0.00141	CbGpPWpGaD
Amisulpride—HTR2B—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000129	0.00141	CbGpPWpGaD
Amisulpride—HTR7—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000128	0.0014	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000128	0.0014	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000127	0.00139	CbGpPWpGaD
Amisulpride—HTR2A—SIDS Susceptibility Pathways—IL6—acquired immunodeficiency syndrome	0.000124	0.00136	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000124	0.00135	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000122	0.00133	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000122	0.00133	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000122	0.00133	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000121	0.00132	CbGpPWpGaD
Amisulpride—DRD3—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.00012	0.00131	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.00012	0.0013	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.00012	0.0013	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000119	0.0013	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000119	0.00129	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000117	0.00128	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000117	0.00128	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.00011	0.0012	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.00011	0.0012	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.00011	0.0012	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000109	0.00119	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000107	0.00117	CbGpPWpGaD
Amisulpride—DRD2—Circadian rythm related genes—IL6—acquired immunodeficiency syndrome	0.000103	0.00113	CbGpPWpGaD
Amisulpride—DRD2—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000102	0.00111	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000101	0.0011	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000101	0.0011	CbGpPWpGaD
Amisulpride—DRD2—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.0001	0.00109	CbGpPWpGaD
Amisulpride—HTR2A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.0001	0.00109	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	9.98e-05	0.00109	CbGpPWpGaD
Amisulpride—HTR2A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	9.87e-05	0.00108	CbGpPWpGaD
Amisulpride—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	9.62e-05	0.00105	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	9.38e-05	0.00102	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	9.38e-05	0.00102	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	9.24e-05	0.00101	CbGpPWpGaD
Amisulpride—DRD2—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	9.17e-05	0.001	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	9.1e-05	0.000993	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	9.09e-05	0.000992	CbGpPWpGaD
Amisulpride—HTR2A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	9.02e-05	0.000984	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	8.96e-05	0.000977	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	8.44e-05	0.000921	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	8.39e-05	0.000916	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	8.33e-05	0.000908	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	8.31e-05	0.000906	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	8.27e-05	0.000902	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	8.19e-05	0.000894	CbGpPWpGaD
Amisulpride—HTR7—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	8.14e-05	0.000888	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	7.67e-05	0.000837	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	7.63e-05	0.000833	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	7.56e-05	0.000825	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	7.55e-05	0.000824	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	7.51e-05	0.000819	CbGpPWpGaD
Amisulpride—HTR2B—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	7.44e-05	0.000812	CbGpPWpGaD
Amisulpride—HTR7—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	7.4e-05	0.000807	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	7.18e-05	0.000783	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	7.18e-05	0.000783	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	7.14e-05	0.000778	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	7.06e-05	0.00077	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	7.06e-05	0.00077	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	7.03e-05	0.000767	CbGpPWpGaD
Amisulpride—DRD3—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	6.92e-05	0.000755	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	6.91e-05	0.000754	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	6.76e-05	0.000737	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	6.43e-05	0.000701	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	6.29e-05	0.000686	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	5.46e-05	0.000596	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	5.38e-05	0.000587	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	5.37e-05	0.000586	CbGpPWpGaD
Amisulpride—DRD2—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	5.3e-05	0.000578	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	5.29e-05	0.000577	CbGpPWpGaD
Amisulpride—HTR2A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	5.21e-05	0.000569	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	4.92e-05	0.000537	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	4.84e-05	0.000528	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	4.81e-05	0.000525	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	4.73e-05	0.000516	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—IL2—acquired immunodeficiency syndrome	4.37e-05	0.000477	CbGpPWpGaD
Amisulpride—HTR7—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	4.35e-05	0.000474	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—IL2—acquired immunodeficiency syndrome	3.99e-05	0.000436	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	3.97e-05	0.000433	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—IL2—acquired immunodeficiency syndrome	3.71e-05	0.000405	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	3.7e-05	0.000403	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—IL2—acquired immunodeficiency syndrome	2.84e-05	0.00031	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	2.83e-05	0.000309	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	2.8e-05	0.000305	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	2.78e-05	0.000304	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.57e-05	0.00028	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.35e-05	0.000256	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.18e-05	0.000238	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.67e-05	0.000182	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.64e-05	0.000179	CbGpPWpGaD
